- Main
Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis
- Divakaruni, Ajit S;
- Hsieh, Wei Yuan;
- Minarrieta, Lucía;
- Duong, Tin N;
- Kim, Kristen KO;
- Desousa, Brandon R;
- Andreyev, Alexander Y;
- Bowman, Caitlyn E;
- Caradonna, Kacey;
- Dranka, Brian P;
- Ferrick, David A;
- Liesa, Marc;
- Stiles, Linsey;
- Rogers, George W;
- Braas, Daniel;
- Ciaraldi, Theodore P;
- Wolfgang, Michael J;
- Sparwasser, Tim;
- Berod, Luciana;
- Bensinger, Steven J;
- Murphy, Anne N
- et al.
Published Web Location
https://doi.org/10.1016/j.cmet.2018.06.001Abstract
Long-chain fatty acid (LCFA) oxidation has been shown to play an important role in interleukin-4 (IL-4)-mediated macrophage polarization (M(IL-4)). However, many of these conclusions are based on the inhibition of carnitine palmitoyltransferase-1 with high concentrations of etomoxir that far exceed what is required to inhibit enzyme activity (EC90 < 3 μM). We employ genetic and pharmacologic models to demonstrate that LCFA oxidation is largely dispensable for IL-4-driven polarization. Unexpectedly, high concentrations of etomoxir retained the ability to disrupt M(IL-4) polarization in the absence of Cpt1a or Cpt2 expression. Although excess etomoxir inhibits the adenine nucleotide translocase, oxidative phosphorylation is surprisingly dispensable for M(IL-4). Instead, the block in polarization was traced to depletion of intracellular free coenzyme A (CoA), likely resulting from conversion of the pro-drug etomoxir into active etomoxiryl CoA. These studies help explain the effect(s) of excess etomoxir on immune cells and reveal an unappreciated role for CoA metabolism in macrophage polarization.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-